Exide Industries Management Guidance Tracker
12 forward-looking guidance items tracked across 3 quarters.
Margins
Management expects EBITDA margins to return to 12-13% range, assuming stable lead prices and volume recovery.
Q3 FY26Potential 150 bps margin improvement in FY27TrackedManagement indicated EBITDA margin could improve by ~150 bps next year, assuming commodity price support and continued cost excellence.
Q4 FY26Price hikes of ~5-6% in aftermarket in Q4, additional 3% in AprilActiveThe company took price increases of 5-6% across segments in Q4 and an additional 3% on April 1 to offset commodity inflation.
Revenue
Solar franchise reached ~800 crore last year and plans to exceed 1,000 crore this fiscal.
Q2 FY26Export business uptick from Q4 FY26ActiveNew geographies and portfolios trials completed; exports expected to improve from January 2026.
Q3 FY26FY27 revenue growth: high single-digit to early double-digitTrackedManagement expects core business to grow at high single-digit to early double-digit in FY27, driven by recovery in declining segments and strong demand in 92% of the business.
Growth
First line (NCM cylindrical for two-wheelers) commissioning; production expected by end of FY26.
Q3 FY26Lithium-ion cell commercial dispatches by Q1 FY27ActiveManagement expects commercial dispatches of lithium-ion cells to begin around March-April 2026, with customer validation samples being sent imminently.
Q4 FY26Core business growth of high single-digit to double-digit in FY27ActiveManagement expects the core lead-acid business to grow at high single-digit to double-digit rates in FY27, driven by strong OEM and replacement demand.
Capex
Planned capex includes ₹1,400 crore for Exide Energy Solutions and ~₹500 crore for the core lead-acid business, funded through internal accruals.
Q4 FY26₹1,400cr investment in Exide Energy in FY27TrackedThe company plans to invest ₹1,400cr in FY27 for the lithium-ion cell manufacturing project, covering capex and working capital.